Device Trial Radar · NCT02880514
In-office Placement of the Propel Mini Sinus Implant in the Frontal Sinus Ostia
Last checked: Nov 20, 2026Latest source record: Dec 10, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Aug 2016
Primary completion
Dec 2016
Study completion Jun 2017
Sponsor
- Lead sponsor
- Intersect ENTNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 26, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A randomized controlled trial
Conditions
- Chronic Sinusitis
Interventions
PROPEL Mini Sinus ImplantDevice
Sinus implant with 370 mcg of mometasone furoate released over 30 days
Balloon Sinus Dilation AloneProcedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patency RateTime frame: Day 30
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Sacramento ENT
Sacramento, California
ENT Assoicates of South Florida
Boca Raton, Florida
ENT of Georgia
Atlanta, Georgia
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.